CISPLATIN INDUCED EMESIS - PRELIMINARY-RESULTS INDICATIVE OF CHANGES IN PLASMA-LEVELS OF 5-HYDROXYTRYPTAMINE

被引：42

作者：

BARNES, NM

GE, J

JONES, WG

NAYLOR, RJ

RUDD, JA

机构：

[1] UNIV LEEDS,COOKRIDGE HOSP,DEPT RADIOTHERAPY,CTR REG RADIOTHERAPY,TUNBRIDGE BLDG,LEEDS LS16 6QB,W YORKSHIRE,ENGLAND

[2] UNIV BRADFORD,SCH PHARM,POSTGRAD STUDIES PHARMACOL,BRADFORD BD7 1DP,ENGLAND

来源：

BRITISH JOURNAL OF CANCER | 1990年 / 62卷 / 05期

关键词：

D O I：

10.1038/bjc.1990.395

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：862 / 864

页数：3

共 15 条

[1] NEUROPHARMACOLOGY OF EMESIS INDUCED BY ANTI-CANCER THERAPY
ANDREWS, PLR
RAPEPORT, WG
SANGER, GJ
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1988, 9 (09) : 334 - 341
[2] CARMICHAEL J, 1989, CANCER CHEMOTH PHARM, V24, P45
[3] 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM TO PREVENT CISPLATIN-INDUCED EMESIS
COSTALL, B
DOMENEY, AM
NAYLOR, RJ
TATTERSALL, FD
[J]. NEUROPHARMACOLOGY, 1986, 25 (08) : 959 - 961
[4] EFFICACY OF ONDANSETRON (GR-38032F) AND THE ROLE OF SEROTONIN IN CISPLATIN-INDUCED NAUSEA AND VOMITING
CUBEDDU, LX
HOFFMANN, IS
FUENMAYOR, NT
FINN, AL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (12) : 810 - 816
[5] PREVENTION OF EMESIS IN PATIENTS RECEIVING CYTOTOXIC DRUGS BY GR38032F, A SELECTIVE 5-HT3 RECEPTOR ANTAGONIST
CUNNINGHAM, D
POPLE, A
FORD, HT
HAWTHORN, J
GAZET, JC
CHALLONER, T
COOMBES, RC
[J]. LANCET, 1987, 1 (8548) : 1461 - 1463
[6] SERUM PROSTAGLANDIN-F2-ALPHA CONCENTRATION IN CARCINOID-SYNDROME
FELDMAN, JM
PLONK, JW
CORNETTE, JC
[J]. PROSTAGLANDINS, 1974, 7 (06): : 501 - 506
[7] THE ROLE OF THE ABDOMINAL VISCERAL INNERVATION AND 5-HYDROXYTRYPTAMINE M-RECEPTORS IN VOMITING INDUCED BY THE CYTO-TOXIC DRUGS CYCLOPHOSPHAMIDE AND CISPLATIN IN THE FERRET
HAWTHORN, J
OSTLER, KJ
ANDREWS, PLR
[J]. QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES, 1988, 73 (01): : 7 - 21
[8] 5-HT3 RECEPTOR ANTAGONISTS INJECTED INTO THE AREA POSTREMA INHIBIT CISPLATIN-INDUCED EMESIS IN THE FERRET
HIGGINS, GA
KILPATRICK, GJ
BUNCE, KT
JONES, BJ
TYERS, MB
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (01) : 247 - 255
[9] PHASE-II TRIALS OF THE SEROTONIN ANTAGONIST GR38032F FOR THE CONTROL OF VOMITING CAUSED BY CISPLATIN
KRIS, MG
GRALLA, RJ
CLARK, RA
TYSON, LB
[J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (01) : 42 - 46
[10] LEIBUNDGUT U, 1987, LANCET, V1, P1198

← 1 2 →